Interferon beta-1a is produced in cultured mammalian cells and has the same aminoacid structure and carbohydrate side-chains as the human cytokine.
Two trials have been published using interferon beta-1a in relapsing-remitting multiple sclerosis:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.